Literature DB >> 33750881

Gut microbiota markers associated with obesity and overweight in Italian adults.

Vanessa Palmas1, Silvia Pisanu1, Aldo Manzin2, Fernanda Velluzzi3, Veronica Madau1, Emanuela Casula1, Andrea Deledda3, Roberto Cusano4, Paolo Uva4, Sarah Vascellari1, Andrea Loviselli3.   

Abstract

In the present study, we characterized the distinctive signatures of the gut microbiota (GM) from overweight/obese patients (OB), and normal-weight controls (NW), both of Sardinian origin. Fecal bacterial composition of 46 OB patients (BMI = 36.6 ± 6.0; F/M = 40/6) was analyzed and compared to that of 46 NW subjects (BMI = 21.6 ± 2.1; F/M = 41/5), matched for sex, age and smoking status, by using 16S rRNA gene sequencing on MiSeq Illumina platform. The gut microbial community of OB patients exhibited a significant decrease in the relative abundance of several Bacteroidetes taxa (i.e. Flavobacteriaceae, Porphyromonadaceae, Sphingobacteriaceae, Flavobacterium, Rikenella spp., Pedobacter spp., Parabacteroides spp., Bacteroides spp.) when compared to NW; instead, several Firmicutes taxa were significantly increased in the same subjects (Lachnospiraceae, Gemellaceae, Paenibacillaceae, Streptococcaceae, Thermicanaceae, Gemella, Mitsuokella, Streptococcus, Acidaminococcus spp., Eubacterium spp., Ruminococcus spp., Megamonas spp., Streptococcus, Thermicanus, Megasphaera spp. and Veillonella spp.). Correlation analysis indicated that body fatness and waist circumference negatively correlated with Bacteroidetes taxa, while Firmicutes taxa positively correlated with body fat and negatively with muscle mass and/or physical activity level. Furthermore, the relative abundance of several bacterial taxa belonging to Enterobacteriaceae family, known to exhibit endotoxic activity, was increased in the OB group compared to NW. The results extend our knowledge on the GM profiles in Italian OB, identifying novel taxa linking obesity and intestine.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33750881      PMCID: PMC7943584          DOI: 10.1038/s41598-021-84928-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  63 in total

1.  Thermicanus aegyptius gen. nov., sp. nov., isolated from oxic soil, a fermentative microaerophile that grows commensally with the thermophilic acetogen Moorella thermoacetica.

Authors:  A S Gössner; R Devereux; N Ohnemüller; G Acker; E Stackebrandt; H L Drake
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

2.  The Gut Microbiome and Its Role in Obesity.

Authors:  Cindy D Davis
Journal:  Nutr Today       Date:  2016 Jul-Aug

3.  The genus Sutterella is a potential contributor to glucose metabolism improvement after Roux-en-Y gastric bypass surgery in T2D.

Authors:  Chen Wang; Hong Zhang; Haijun Liu; Hongwei Zhang; Yuqian Bao; Jianzhong Di; Cheng Hu
Journal:  Diabetes Res Clin Pract       Date:  2020-03-16       Impact factor: 5.602

4.  Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla.

Authors:  Michael A Mahowald; Federico E Rey; Henning Seedorf; Peter J Turnbaugh; Robert S Fulton; Aye Wollam; Neha Shah; Chunyan Wang; Vincent Magrini; Richard K Wilson; Brandi L Cantarel; Pedro M Coutinho; Bernard Henrissat; Lara W Crock; Alison Russell; Nathan C Verberkmoes; Robert L Hettich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

Review 5.  Gut microbiota and obesity.

Authors:  Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2015-10-12       Impact factor: 9.261

Review 6.  Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases.

Authors:  Jingyuan Chen; Yuan Guo; Yajun Gui; Danyan Xu
Journal:  Lipids Health Dis       Date:  2018-01-22       Impact factor: 3.876

7.  Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease.

Authors:  Sara Carbajo-Pescador; David Porras; María Victoria García-Mediavilla; Susana Martínez-Flórez; María Juarez-Fernández; María José Cuevas; José Luis Mauriz; Javier González-Gallego; Esther Nistal; Sonia Sánchez-Campos
Journal:  Dis Model Mech       Date:  2019-04-30       Impact factor: 5.758

8.  A Metagenomic Meta-analysis Reveals Functional Signatures of Health and Disease in the Human Gut Microbiome.

Authors:  Courtney R Armour; Stephen Nayfach; Katherine S Pollard; Thomas J Sharpton
Journal:  mSystems       Date:  2019-05-14       Impact factor: 6.496

9.  Short Chain Fatty Acids and Fecal Microbiota Abundance in Humans with Obesity: A Systematic Review and Meta-Analysis.

Authors:  Kyu Nam Kim; Yao Yao; Sang Yhun Ju
Journal:  Nutrients       Date:  2019-10-18       Impact factor: 5.717

Review 10.  Defining the human microbiome.

Authors:  Luke K Ursell; Jessica L Metcalf; Laura Wegener Parfrey; Rob Knight
Journal:  Nutr Rev       Date:  2012-08       Impact factor: 7.110

View more
  34 in total

1.  Repetitive transcranial direct current stimulation modulates the brain-gut-microbiome axis in obese rodents.

Authors:  Agata Ziomber-Lisiak; Katarzyna Talaga-Ćwiertnia; Agnieszka Sroka-Oleksiak; Artur D Surówka; Kajetan Juszczak; Magdalena Szczerbowska-Boruchowska
Journal:  Pharmacol Rep       Date:  2022-08-09       Impact factor: 3.919

2.  Enrichment of sulphate-reducers and depletion of butyrate-producers may be hyperglycaemia signatures in the diabetic oral microbiome.

Authors:  Camilla Pedrosa Vieira Lima; Daniela Corrêa Grisi; Maria Do Carmo Machado Guimarães; Loise Pedrosa Salles; Paula de Castro Kruly; Thuy Do; Luiz Gustavo Dos Anjos Borges; Naile Dame-Teixeira
Journal:  J Oral Microbiol       Date:  2022-06-03       Impact factor: 5.833

Review 3.  From Gut Microbiota through Low-Grade Inflammation to Obesity: Key Players and Potential Targets.

Authors:  Claudia Vetrani; Andrea Di Nisio; Stavroula A Paschou; Luigi Barrea; Giovanna Muscogiuri; Chiara Graziadio; Silvia Savastano; Annamaria Colao
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

4.  Gut Microbiota Markers and Dietary Habits Associated with Extreme Longevity in Healthy Sardinian Centenarians.

Authors:  Vanessa Palmas; Silvia Pisanu; Veronica Madau; Emanuela Casula; Andrea Deledda; Roberto Cusano; Paolo Uva; Andrea Loviselli; Fernanda Velluzzi; Aldo Manzin
Journal:  Nutrients       Date:  2022-06-12       Impact factor: 6.706

5.  Gut dysbiosis and body composition in cirrhosis.

Authors:  Roman Maslennikov; Vladimir Ivashkin; Aliya Alieva; Elena Poluektova; Anna Kudryavtseva; George Krasnov; Maria Zharkova; Yuri Zharikov
Journal:  World J Hepatol       Date:  2022-06-27

Review 6.  Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation.

Authors:  Andrea Deledda; Giuseppe Annunziata; Gian Carlo Tenore; Vanessa Palmas; Aldo Manzin; Fernanda Velluzzi
Journal:  Antioxidants (Basel)       Date:  2021-04-29

7.  Characterization of the gut microbiota in hemodialysis patients with sarcopenia.

Authors:  Qifan Zhou; Hailin Zhang; Lixia Yin; Guilian Li; Wenxue Liang; Guanjie Chen
Journal:  Int Urol Nephrol       Date:  2021-11-29       Impact factor: 2.266

8.  Characteristics of the Intestinal Microorganisms in Middle-Aged and Elderly Patients: Effects of Smoking.

Authors:  Hai-Tao Yang; Wen-Juan Xiu; Jing-Kun Liu; Yi Yang; Yan-Jun Zhang; Ying-Ying Zheng; Ting-Ting Wu; Xian-Geng Hou; Cheng-Xin Wu; Yi-Tong Ma; Xiang Xie
Journal:  ACS Omega       Date:  2022-01-05

9.  Associations of physical activity with gut microbiota in pre-adolescent children.

Authors:  Sara Santarossa; Alexandra R Sitarik; Christine Cole Johnson; Jia Li; Susan V Lynch; Dennis R Ownby; Alex Ramirez; Germaine Lm Yong; Andrea E Cassidy-Bushrow
Journal:  Phys Act Nutr       Date:  2021-12-31

Review 10.  Nutritional Management in Bariatric Surgery Patients.

Authors:  Andrea Deledda; Stefano Pintus; Andrea Loviselli; Michele Fosci; Giovanni Fantola; Fernanda Velluzzi
Journal:  Int J Environ Res Public Health       Date:  2021-11-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.